Center for Alcohol and Addiction Studies, Department of Behavioral and Social Science, Brown University, Providence, RI, USA; Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Center for Alcohol and Addiction Studies, Department of Behavioral and Social Science, Brown University, Providence, RI, USA; Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, and National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA; Center for Alcohol and Addiction Studies, Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA.
Drug Alcohol Depend. 2018 Apr 1;185:339-346. doi: 10.1016/j.drugalcdep.2017.12.037. Epub 2018 Feb 23.
The stigma of drug addiction is associated with negative perceptions and can be a barrier to treatment. With the rise in opioid overdose deaths, understanding stigmatizing attitudes towards individuals who use opioids is a crucial matter. There is a lack of opioid use research on stigma and, therefore, we aimed to discern stigmatizing attitudes towards people with opioid addiction. A randomized, between-subjects case vignette study (n = 2605) was conducted with a nation-wide online survey. Participants rated a hypothetical individual addicted to opioids on different dimensions of stigma after seeing one version of a vignette that varied by three conditions: 1) a male versus a female, 2) an individual labeled as being a "drug addict" versus having an "opioid use disorder" and 3) an individual whose use started by taking prescription opioids from a friend versus receiving a prescription from a doctor. Our results indicated that there were higher stigmatizing attitudes overall towards a male, an individual labeled as a "drug addict" and an individual who took prescription opioids from a friend. Interaction effects also showed that a female labeled with an "opioid use disorder" and male labeled as a "drug addict" were rated with higher stigma. The findings from our study are the first to show that information about gender, precipitating events and language matter when assessing stigma and opioid use and may affect the delivery of patient care.
吸毒成瘾的污名将人们对吸毒者的负面看法联系起来,可能成为治疗的障碍。随着阿片类药物过量死亡人数的增加,了解人们对使用阿片类药物者的污名化态度是至关重要的。关于污名化的阿片类药物使用研究很少,因此,我们旨在了解人们对阿片类药物成瘾者的污名化态度。本研究采用随机、被试间病例情节研究(n=2605),通过全国性在线调查进行。参与者在看到一个病例情节的一个版本后,根据三个条件对一个假设的阿片类药物成瘾者的不同维度进行了评分:1)男性与女性,2)被贴上“瘾君子”标签与患有“阿片类药物使用障碍”标签,3)一个从朋友那里获取处方阿片类药物的使用者与从医生那里获取处方的使用者。我们的结果表明,总体而言,人们对男性、被贴上“瘾君子”标签的个体以及从朋友那里获取处方阿片类药物的个体持有的污名化态度更高。交互效应还表明,被贴上“阿片类药物使用障碍”标签的女性和被贴上“瘾君子”标签的男性的评分更高。本研究的结果首次表明,在评估污名化和阿片类药物使用时,有关性别、引发事件和语言的信息很重要,可能会影响患者护理的提供。